Home > Pressrelease > Blood Platelets Market size to surpass $7bn by 2030

Blood Platelets Market size to surpass $7bn by 2030

  • Published Date: October 27, 2022

Blood Platelets Market size is anticipated to exceed USD 7 Billion by 2030, according to a new research report by Global Market Insights Inc.

Rising prevalence of blood-related disorders is fueling the need for blood transfusions and augmenting the market progression. Meanwhile, the increasing availability of U.S. FDA-approved blood transfusion products, comprising blood platelets, is also fostering market development. Advancements in technology have helped the sector enhance its blood collection and storage capabilities in recent years.

Strong demand from transplant, oncology, and pediatric patients to stimulate segment outlook

Whole blood derived platelets segment accounted for 39% revenue share in 2021 and is anticipated to register over 4% CAGR through 2030. This is attributed to increasing demand from oncology, transplant, and pediatric patients. According to Association for the Advancement of Blood and Biotherapies, whole blood transfusions are typically used in events of life-threatening haemorrhage, when platelet and volume expansion are required.

Browse key industry insights spread across 179 pages with 227 market data tables & 17 figures & charts from the report, “Blood Platelets Market Size By Platelet (Whole Blood Derived Platelets, Apheresis Derived Platelets), By Application (Hemophilia, Thrombocytopenia, Perioperative Indications, Platelet Function Disorders, Hemato-oncology), By End-use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 – 2030” in detail along with the table of contents:

Increasing occurrence across developing economies to promote perioperative indications segment revenues

Blood platelets market from perioperative indications segment was valued at over USD 680 million in 2021 and is projected to record over 4% CAGR from 2022 to 2030. Driven by its rising prevalence and risk of perioperative indications in developing economies, blood platelets therapies have become increasingly common. Patients suffering from perioperative indications require blood platelets for reducing the worsening effects of this condition, which is largely shaping the segment share.

Better availability of highly trained medical professionals to drive hospitals segment growth

Hospitals segment accounted for a valuation of over USD 3.5 billion in 2021 driven by the mounting use of blood transfusion procedures inside hospital settings. This is owing to the availability of highly trained medical professionals that help deliver enhanced results to patients. In addition, rising hospital admissions due to chronic and blood disorders are also likely to accelerate market trends.

Rising blood donation initiatives to shape the Asia Pacific market value

Asia Pacific blood platelets market was valued at over USD 1.5 billion in 2021 and the study predicts that it may register over 5.5% CAGR through 2022-2030. Increasing cases of blood-related disorders like thrombocytopenia, hemophilia, and leukocytosis are boosting the regional scenario. Meanwhile, rising number of surgeries and voluntary blood donation programs are more predominantly shaping regional progress.

Relief programs by industry giants to shape the competitive market landscape

Some of the contenders in the blood platelets market are Brazilian Red Cross, Canadian Blood Services, French Red Cross, German Red Cross, Indian Red Cross Society, Italian Red Cross, Japanese Red Cross Society, and others. Many of these companies are focusing on organizing relief programs to meet the patients’ medical requirements.

Authors: Sumant Ugalmugle, Rupali Swain

Explore More on Related Topics: